Literature DB >> 12810180

Health-related quality of life and cost of ambulatory care in osteoporosis: how may such outcome measures be valuable information to health decision makers and payers?

O Ethgen1, V Tellier, W B Sedrine, J De Maeseneer, C Gosset, J-Y Reginster.   

Abstract

The objective was to quantify the outcome of osteoporosis (OP) in terms of health-related quality of life (HR-QOL) and cost of ambulatory care and to look at the association between these two outcomes variables. A cross-sectional health survey of 4800 Belgian individuals over the age of 45 years was used. Individuals having reported OP were retrieved and for each of them, at least two matched individuals for age, sex, residency location, and health insurance status were identified. All individuals were assessed with the SF-36. The two major health insurance providers furnished cost value for ambulatory care. HR-QOL and cost data were compared between the OP group and control group. Beta-coefficients from linear regression were calculated to give information on the relative importance of the association between each SF-36 dimensions and cost of ambulatory care. Of 4796 individuals appropriately surveyed, 221 (4.8%) reported OP. The control group included 651 individuals. The OP group experienced impaired HR-QOL compared to their matched counterparts, all the difference in mean or median SF-36 scores being significant at the level of P < 0.001. Osteoporotic respondents averaged 816 in cost of ambulatory care whereas controls averaged 579 (P < 0.001). When looking at detailed comparisons between categories of cost, costs in the OP group far exceeded those in the control group, all the differences being significant at the level of P < 0.001 except for home health nurse (P = 0.012). In the OP group, vitality dimensions played the most important role in the determination of cost (beta = -0.28, P < 0.001), followed by physical functioning (beta = -0.26, P < 0.01), general health, and social functioning (beta = -0.23, P < 0.01). This study evidences the burden of OP in terms of HR-QOL and cost of ambulatory care. Exploring the association between HR-QOL and cost show that mental dimension such as vitality can play an important role in the determination of cost. Conclusively, they should not be neglected in future management of OP.

Entities:  

Mesh:

Year:  2003        PMID: 12810180     DOI: 10.1016/s8756-3282(03)00089-9

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  13 in total

1.  A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs.

Authors:  V Rabenda; N Burlet; O Ethgen; F Raeman; J Belaiche; J-Y Reginster
Journal:  Ann Rheum Dis       Date:  2004-11-04       Impact factor: 19.103

2.  The direct and indirect costs of the chronic management of osteoporosis: a prospective follow-up of 3440 active subjects.

Authors:  V Rabenda; C Manette; R Lemmens; A-M Mariani; N Struvay; J-Y Reginster
Journal:  Osteoporos Int       Date:  2006-06-24       Impact factor: 4.507

3.  Determinants of health-related quality of life in women with vertebral fractures.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; George Ioannidis; Jacques P Brown; Anjali Pathak; David A Hanley; Robert G Josse; Rolf J Sebaldt; Wojciech P Olszynski; Alan Tenenhouse; Timothy M Murray; Annie Petrie; Charles H Goldsmith; Jonathan D Adachi
Journal:  Osteoporos Int       Date:  2005-12-09       Impact factor: 4.507

4.  Evaluation of a pulsed phase-locked loop system for noninvasive tracking of bone deformation under loading with finite element and strain analysis.

Authors:  Frederick Serra-Hsu; Jiqi Cheng; Ted Lynch; Yi-Xian Qin
Journal:  Physiol Meas       Date:  2011-07-15       Impact factor: 2.833

Review 5.  Quality-of-life issues in osteoporosis.

Authors:  Stuart L Silverman
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

6.  Reduction of pain and fracture incidence after kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis.

Authors:  Ingo A Grafe; Katharina Da Fonseca; Jochen Hillmeier; Peter-Jürgen Meeder; Martin Libicher; Gerd Nöldge; Hubert Bardenheuer; Walter Pyerin; Linus Basler; Christel Weiss; Rod S Taylor; Peter Nawroth; Christian Kasperk
Journal:  Osteoporos Int       Date:  2005-08-03       Impact factor: 4.507

Review 7.  The impact of fragility fracture on health-related quality of life : the importance of antifracture therapy.

Authors:  Ted Xenodemetropoulos; Shawn Davison; George Ioannidis; Jonathan D Adachi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

8.  Alendronate improves QOL of postmenopausal women with osteoporosis.

Authors:  Hisaya Kawate; Keizo Ohnaka; Masahiro Adachi; Suminori Kono; Hideyuki Ikematsu; Hisashi Matsuo; Kazumi Higuchi; Takehiko Takayama; Ryoichi Takayanagi
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

9.  Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures.

Authors:  Elisabetta Romagnoli; Vincenzo Carnevale; Italo Nofroni; Emilio D'Erasmo; Federica Paglia; Simona De Geronimo; Jessica Pepe; Natalia Raejntroph; Marianna Maranghi; Salvatore Minisola
Journal:  Osteoporos Int       Date:  2004-04-30       Impact factor: 4.507

10.  Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures.

Authors:  Lucinda Strycker Orsini; Matthew D Rousculp; Stacey R Long; Shaohung Wang
Journal:  Osteoporos Int       Date:  2004-09-01       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.